癌免疫の要素と癌免疫セットポイント
1Genentech, 1 DNA Way, South San Francisco, California 94080, USA.
Nature
|January 20, 2017
まとめ
免疫療法はがん治療において有望ですが,持続的な反応は限られています. 腫瘍,宿主,環境によって影響される 癌の免疫セットポイントを理解することは 患者の結果を改善する鍵です
科学分野:
- 腫瘍学
- 免疫学
- 癌 研究
背景:
- 免疫療法,特にCTLA4とPD-L1/PD-1を標的とする抗体を用いるのが有効ながん治療である.
- 現在の免疫療法に対する持続的な反応は,患者のサブセットにおいてのみ観察される.
- 現在の目標を超えてがんに対する免疫に関する包括的な理解が必要である.
研究 の 目的:
- 抗がん免疫反応に影響を与える多面的な要因を探る
- 免疫療法に対する患者の反応を予測できる免疫プロフィールを定義する.
- "がん免疫セットポイント"という概念を個人の固有免疫状態として導入する.
主な方法:
- 予測免疫プロフィールを定義する臨床試験のレビュー
- 癌と免疫のサイクル分析
- 腫瘍,宿主,環境要因の統合
主要な成果:
- ガンに対する免疫は 腫瘍,宿主,環境要因の 複雑な相互作用によって支配されます
- これらの要因は,抗がん反応の強さとタイミングを決定する.
- 免疫プロファイルが免疫療法反応の予測要因として浮上しています.
結論:
- "がん免疫セットポイント"は,がんに関する個人の全体的な免疫状態をまとめます.
- 免疫療法の有効性を高めるには,がん免疫に対するより広い視点が必要である.
- 癌の免疫セットポイントを特定し特徴づけることは,よりパーソナライズされた治療戦略につながる可能性があります.
関連する概念動画
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Stem Cells and Tumor Maintenance
6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K


